SG120237A1 - Non-essential amino acids containing pharmaceutical composition and uses thereof - Google Patents

Non-essential amino acids containing pharmaceutical composition and uses thereof

Info

Publication number
SG120237A1
SG120237A1 SG200504722A SG200504722A SG120237A1 SG 120237 A1 SG120237 A1 SG 120237A1 SG 200504722 A SG200504722 A SG 200504722A SG 200504722 A SG200504722 A SG 200504722A SG 120237 A1 SG120237 A1 SG 120237A1
Authority
SG
Singapore
Prior art keywords
amino acids
pharmaceutical composition
essential amino
acids containing
containing pharmaceutical
Prior art date
Application number
SG200504722A
Inventor
Xavier M Prof Leverve
Original Assignee
Innogene Kalbiotech Pte Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Innogene Kalbiotech Pte Ltd filed Critical Innogene Kalbiotech Pte Ltd
Publication of SG120237A1 publication Critical patent/SG120237A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/401Proline; Derivatives thereof, e.g. captopril
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • A61K31/405Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/4172Imidazole-alkanecarboxylic acids, e.g. histidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SG200504722A 2004-08-13 2005-07-29 Non-essential amino acids containing pharmaceutical composition and uses thereof SG120237A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04019294 2004-08-13

Publications (1)

Publication Number Publication Date
SG120237A1 true SG120237A1 (en) 2006-03-28

Family

ID=34926169

Family Applications (1)

Application Number Title Priority Date Filing Date
SG200504722A SG120237A1 (en) 2004-08-13 2005-07-29 Non-essential amino acids containing pharmaceutical composition and uses thereof

Country Status (3)

Country Link
KR (1) KR20060050428A (en)
SG (1) SG120237A1 (en)
TW (1) TWI377937B (en)

Also Published As

Publication number Publication date
TW200605798A (en) 2006-02-16
TWI377937B (en) 2012-12-01
KR20060050428A (en) 2006-05-19

Similar Documents

Publication Publication Date Title
IL173726A (en) Pharmaceutical compositions comprising n-n-dihaloamino acid and uses thereof
EP1857489A4 (en) Microparticle and pharmaceutical composition
EP1843661A4 (en) Compositions comprising o-acetylsalicyl derivatives of aminocarbohydrates and amino acids
IL186959A0 (en) Peptides and pharmaceutical compositions containing the same
IL177168A0 (en) N-sulphonylpyrrole derivatives and pharmaceutical compositions containing the same
IL178294A0 (en) Thienopyridine derivatives and pharmaceutical compositions containing the same
GB0413730D0 (en) A pharmaceutical composition and its use
IL179795A0 (en) A pharmaceutical composition and its use
IL218090A0 (en) In vivo incorporation of alkynyl amino acids into proteins in eubacteria
IL182020A0 (en) Pharmaceutical composition comprising diclofenac
IL179207A0 (en) Pyrrole derivatives and pharmaceutical compositions containing the same
IL221323A0 (en) 1-methyl-1h- pyridin-2-one- phenanthridine derivatives and pharmaceutical compositions containing the same
EP1865953A4 (en) Composition comprising n-propanoyl derivatives of amino acids, aminocarbohydrates and derivatives thereof
EP1773369A4 (en) Pharmaceutical compositions and methods for peptide treatment
EP1890677A4 (en) Pharmaceutical compositions and use thereof
PL1890720T3 (en) Pharmaceutical compositions comprising casein derived peptides and methods of use thereof
IL177499A0 (en) Thio-containing hydroxy-6-phenylphenanthridine derivatives and pharmaceutical compositions containing the same
PL1799188T3 (en) Use of peptides as an antioxidant agent for the preparation of a cosmetic and/or pharmaceutical composition
IL182126A (en) Compositions containing 5-phenoxyalkoxypsoralen derivatives and uses thereof
IL221395A0 (en) Pharmaceutical compositions comprising alpha ketoamide derivatives and uses thereof
EP1765373A4 (en) Ozonidzed pharmaceutical composition and method
ZA200702938B (en) Peptides and APL-type derivatives of Hsp60 and pharmaceutical compositions
IL181730A0 (en) Benzodiazinone derivatives and pharmaceutical compositions containing the same
IL177498A0 (en) Difluoroethoxy -substituted hydroxy-6-phenylphenanthridine derivatives and pharmaceutical compositions containing the same
EP1884510A4 (en) N-substituted phenylacetamide derivative and pharmaceutical composition comprising the same